Form4insider filings, from the source

Company · CIK 0001339970 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq

aTYR PHARMA INC · LIFE

Insider activity reported against this company. All insider holders · On EDGAR ↗

1M3M6M1Y2YAll datashares as filed — not split-adjusted
Open-market buys & salesbuys $12.2M · 30sales $3.1M · 4net $9.1M
$10k$10k$100k$100k$1M$1M$10M$10MbuyssalesMay 2015Dec 2015Jul 2016Mar 2017Oct 2017May 2018Dec 2018

Reported at this company — common stock

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Dec 20, 2018 PForm 4 →Dec 26, 4:15 pm ESTJohn MendleinDirector245,000$0.4214$103,247615,382+66.1% plan? late
Nov 26, 2018 PForm 4 →Nov 28, 7:12 pm ESTPaul SchimmelDirector147,225$0.542$79,796882,302+20.0% plan?
Sep 19, 2018 PForm 4 →Sep 21, 4:38 pm EDTJill Marie BroadfootChief Financial Officer64,000$0.8259$52,85590,000+246% plan?
Sep 14, 2018 PForm 4 →Sep 18, 6:12 pm EDTJill Marie BroadfootChief Financial Officer26,000$0.7329$19,05526,000— plan?
Aug 31, 2018 PForm 4 →Sep 5, 4:04 pm EDTPaul SchimmelDirector42,749$0.7359$31,461735,077+6.17% plan?
Aug 29, 2018 PForm 4 →Aug 31, 4:11 pm EDTPaul SchimmelDirector164,411$0.7394$121,573692,328+31.1% plan?
May 31, 2018 MForm 4 →Jun 7, 7:29 pm EDTAshraf AmanullahSee Remarks3,333——26,264— plan? late
May 18, 2018 PForm 4 →May 21, 6:50 pm EDTPaul SchimmelDirector150,000$0.9963$149,445527,917+39.7% plan?
May 14, 2018 SForm 4 →May 16, 5:15 pm EDTEcoR1 Capital Fund Qualified, L.P.10% Owner3,209,316$0.9345$2,999,0560−100% plan?
Feb 8, 2018 SForm 4 →Feb 8, 8:43 pm ESTJohn T BlakeSenior Vice President, Finance1,402$3.40$4,7671,932−42.1% plan?
Feb 8, 2018 SForm 4 →Feb 8, 8:39 pm ESTAshraf AmanullahSee Remarks1,402$3.40$4,7671,932−42.1% plan?
Feb 7, 2018 MForm 4 →Feb 8, 8:43 pm ESTJohn T BlakeSenior Vice President, Finance3,334——3,334— plan?
Feb 7, 2018 MForm 4 →Feb 8, 8:39 pm ESTAshraf AmanullahSee Remarks3,334——3,334— plan?
Nov 8, 2017 SForm 4 →Dec 14, 3:46 pm ESTEcoR1 Capital Fund Qualified, L.P.10% Owner13,832$4.08$56,4753,209,316−0.43% plan? late
Oct 1, 2017 PForm 4 →Dec 14, 3:46 pm ESTEcoR1 Capital Fund Qualified, L.P.10% Owner29,607$4.84$143,3333,223,148+0.93% plan? late
Aug 31, 2017 PForm 4 →Sep 5, 8:22 pm EDTPaul SchimmelDirector94,336$2.65$249,990377,917+33.3% plan?
Aug 31, 2017 PForm 4 →Sep 5, 7:41 pm EDTJohn MendleinCEO and Director, Director37,736$2.65$100,000367,883+11.4% plan?
Apr 24, 2017 PForm 4 →Apr 26, 5:02 pm EDTJohn MendleinCEO and Director, Director124$3.00$372327,647+0.04% plan?
Apr 18, 2017 PForm 4 →Apr 20, 7:04 pm EDTJohn MendleinCEO and Director, Director2,552$3.00$7,656327,523+0.79% plan?
Dec 20, 2016 PForm 4 →Dec 22, 11:53 am ESTPaul SchimmelDirector25,000$2.28$56,928721,814+3.59% plan?
Dec 20, 2016 PForm 4 →Dec 21, 6:37 pm ESTAshraf AmanullahVice President, Manufacturing11,000$2.25$24,74911,000— plan?
Dec 19, 2016 PForm 4 →Dec 21, 11:54 am ESTJohn MendleinCEO and Director, Director69,000$2.20$151,662324,971+27.0% plan?
Dec 15, 2016 PForm 4 →Dec 19, 7:41 pm ESTPaul SchimmelDirector50,000$2.48$123,885696,814+7.73% plan?
Sep 23, 2016 GForm 4 →Dec 19, 7:41 pm ESTPaul SchimmelDirector25,144——646,814— plan? late
May 9, 2016 PForm 4 →May 11, 8:54 pm EDTGrove MatsuokaSee Remarks12,412$3.04$37,72912,412— plan?
Apr 14, 2016 PForm 4 →Apr 15, 5:46 pm EDTPaul SchimmelDirector66,219$4.18$276,93453,012— plan?
Apr 13, 2016 PForm 4 →Apr 14, 7:20 pm EDTPaul SchimmelDirector9,835$3.85$37,865249,962+4.10% plan?
Apr 12, 2016 PForm 4 →Apr 13, 6:34 pm EDTPaul SchimmelDirector9,127$3.71$33,901240,127+3.95% plan?
Apr 11, 2016 PForm 4/A →Apr 13, 6:32 pm EDTPaul SchimmelDirector32,659$3.57$116,534233,581+16.3% plan?
Apr 11, 2016 PForm 4 →Apr 12, 3:57 pm EDTPaul SchimmelDirector32,659$3.57$116,535220,231+17.4% plan? amended
Apr 8, 2016 PForm 4 →Apr 11, 12:39 pm EDTPaul SchimmelDirector85,000$3.22$273,649187,572+82.9% plan?
Apr 7, 2016 PForm 4 →Apr 8, 12:19 pm EDTPaul SchimmelDirector40,000$3.19$127,584102,572+63.9% plan?
Apr 6, 2016 PForm 4 →Apr 7, 3:40 pm EDTPaul SchimmelDirector25,000$3.20$80,00062,572+66.5% plan?
Apr 5, 2016 PForm 4 →Apr 7, 3:25 pm EDTJohn MendleinCEO and Director, Director2,500$3.52$8,800250,971+1.01% plan?
Apr 5, 2016 PForm 4 →Apr 6, 7:19 pm EDTJohn MendleinCEO and Director, Director2,500$3.55$8,875248,471+1.02% plan?
Apr 5, 2016 PForm 4 →Apr 6, 7:19 pm EDTPaul SchimmelDirector25,000$3.52$88,11837,572+199% plan?
Sep 16, 2015 GForm 4 →Jan 29, 2016, 6:08 pm ESTPaul SchimmelDirector11,925——634,242— plan? late
May 12, 2015 CForm 4 →May 14, 9:35 pm EDTJohn K ClarkeDirector1,850,464——1,758,158— plan?
May 12, 2015 CForm 4 →May 14, 9:29 pm EDTJohn MendleinCEO and Executive Chairman, Director24,055——245,971— plan?
May 12, 2015 CForm 4 →May 14, 9:27 pm EDTPolaris Venture Management Co. V, L.L.C. +410% Owner1,827,992——17,638— plan?
May 12, 2015 CForm 4 →May 14, 9:24 pm EDTCHP II LP +310% Owner1,758,158——1,758,158— plan?
May 12, 2015 PForm 4 →May 14, 9:24 pm EDTSrinivas AkkarajuDirector320,000$14.00$4,480,0001,866,126+20.7% plan?
May 12, 2015 CForm 4 →May 14, 9:24 pm EDTSrinivas AkkarajuDirector1,546,126——1,546,126— plan?
May 12, 2015 CForm 4 →May 14, 9:23 pm EDTAlta Partners VIII, L.P. +410% Owner1,778,064——1,778,064— plan?
May 12, 2015 CForm 4 →May 14, 9:20 pm EDTPaul SchimmelDirector547,353——646,167— plan?
May 12, 2015 PForm 4 →May 14, 9:19 pm EDTSofinnova Venture Partners IX, L.P. +410% Owner320,000$14.00$4,480,0001,866,126+20.7% plan?
May 12, 2015 CForm 4 →May 14, 9:19 pm EDTSofinnova Venture Partners IX, L.P. +410% Owner1,546,126——1,546,126— plan?
May 12, 2015 CForm 4 →May 14, 9:19 pm EDTAmir NashatDirector1,827,992——17,638— plan?
May 12, 2015 PForm 4 →May 13, 1:00 pm EDTJames E Flynn +510% Owner50,000$14.00$700,000255,764+24.3% plan?
May 12, 2015 CForm 4 →May 13, 1:00 pm EDTJames E Flynn +510% Owner461,528——230,764— plan?
May 12, 2015 CForm 4 →May 12, 9:46 pm EDTDP VIII Associates, L.P. +610% Owner13,414——13,414— plan?
May 12, 2015 CForm 4 →May 12, 9:41 pm EDTDomain Partners VIII, L.P. +610% Owner1,807,820——1,807,820— plan?

Reported at this company — derivatives (options, RSUs, warrants)

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Feb 6, 2019 AForm 4 →Feb 8, 8:12 pm ESTNancy KruegerGeneral Counsel125,000——125,000—
Feb 6, 2019 AForm 4 →Feb 8, 7:16 pm ESTJill Marie BroadfootChief Financial Officer75,000——25,000—
Feb 6, 2019 AForm 4 →Feb 8, 7:09 pm ESTSanjay ShuklaPresident and CEO250,000——50,000—
Jul 30, 2018 AForm 4 →Aug 1, 4:56 pm EDTJill Marie BroadfootChief Financial Officer200,000——200,000—
May 31, 2018 MForm 4 →Jun 7, 7:29 pm EDTAshraf AmanullahSee Remarks3,333——3,333— late
May 15, 2018 AForm 4 →May 17, 5:15 pm EDTJames C BlairDirector20,000——20,000—
May 15, 2018 AForm 4 →May 17, 4:38 pm EDTPaul SchimmelDirector20,000——20,000—
May 15, 2018 AForm 4 →May 17, 4:36 pm EDTAmir NashatDirector20,000——20,000—
May 15, 2018 AForm 4 →May 17, 4:32 pm EDTJohn MendleinDirector20,000——20,000—
May 15, 2018 AForm 4 →May 17, 4:27 pm EDTJeffrey S. HatfieldDirector20,000——20,000—
May 15, 2018 AForm 4 →May 17, 4:23 pm EDTTimothy P CoughlinDirector20,000——20,000—
May 15, 2018 AForm 4 →May 17, 4:16 pm EDTJohn K ClarkeDirector20,000——20,000—
Feb 6, 2018 AForm 4 →Feb 8, 8:51 pm ESTSanjay ShuklaPresident and CEO300,000——300,000—
Feb 6, 2018 AForm 4 →Feb 8, 8:47 pm ESTDavid John KingChief Scientific Officer150,000——150,000—
Feb 6, 2018 AMForm 4 →Feb 8, 8:43 pm ESTJohn T BlakeSenior Vice President, Finance78,334——6,666—
Feb 6, 2018 AMForm 4 →Feb 8, 8:39 pm ESTAshraf AmanullahSee Remarks103,334——6,666—
Jan 2, 2018 AForm 4 →Jan 2, 7:49 pm ESTJohn MendleinDirector32,000——32,000—
Nov 1, 2017 AForm 4 →Nov 3, 1:56 pm EDTSanjay ShuklaPresident and CEO450,000——450,000—
Aug 31, 2017 PForm 4 →Sep 5, 8:22 pm EDTPaul SchimmelDirector35,376——35,376—
Aug 31, 2017 PForm 4 →Sep 5, 7:41 pm EDTJohn MendleinCEO and Director, Director14,151——14,151—
May 9, 2017 AForm 4 →May 11, 7:09 pm EDTPaul SchimmelDirector20,000——20,000—
May 9, 2017 AForm 4 →May 11, 7:05 pm EDTAmir NashatDirector20,000——20,000—
May 9, 2017 AForm 4 →May 11, 7:01 pm EDTJeffrey S. HatfieldDirector20,000——20,000—
May 9, 2017 AForm 4 →May 11, 6:57 pm EDTMark Alan GoldbergDirector20,000——20,000—
May 9, 2017 AForm 4 →May 11, 6:54 pm EDTTimothy P CoughlinDirector20,000——20,000—
May 9, 2017 AForm 4 →May 11, 6:49 pm EDTJohn K ClarkeDirector20,000——20,000—
May 9, 2017 AForm 4 →May 11, 6:45 pm EDTSrinivas AkkarajuDirector20,000——20,000—
May 9, 2017 AForm 4 →May 11, 4:14 pm EDTJames C BlairDirector20,000——20,000—
Apr 7, 2017 AForm 4 →Apr 10, 5:29 pm EDTTimothy P CoughlinDirector32,000——32,000—
Apr 3, 2017 AForm 4 →Apr 4, 4:07 pm EDTJeffrey S. HatfieldDirector32,000——32,000—
Feb 7, 2017 AForm 4 →Feb 9, 4:36 pm ESTSanjay ShuklaChief Medical Officer65,000——65,000—
Feb 7, 2017 AForm 4 →Feb 9, 4:31 pm ESTSanuj K. RavindranChief Business Officer40,000——40,000—
Feb 7, 2017 AForm 4 →Feb 9, 4:27 pm ESTJohn MendleinCEO and Director, Director185,000——185,000—
Feb 7, 2017 AForm 4 →Feb 9, 4:24 pm ESTGrove MatsuokaSee Remarks20,000——20,000—
Feb 7, 2017 AForm 4 →Feb 9, 4:09 pm ESTDavid John KingSee Remarks65,000——65,000—
Feb 7, 2017 AForm 4 →Feb 9, 4:06 pm ESTJohn T BlakeSenior Vice President, Finance65,000——10,000—
Feb 7, 2017 AForm 4 →Feb 9, 4:03 pm ESTAshraf AmanullahVice President, Manufacturing45,000——10,000—
Sep 21, 2016 AForm 4 →Sep 22, 4:53 pm EDTDavid John KingSee Remarks145,000——145,000—
Sep 13, 2016 AForm 4 →Sep 15, 7:26 pm EDTAndrew CubittVP, Product Protection25,000——25,000—
Sep 13, 2016 AForm 4 →Sep 15, 6:59 pm EDTSanuj K. RavindranChief Business Officer45,500——45,500—
Sep 13, 2016 AForm 4 →Sep 15, 6:57 pm EDTAshraf AmanullahVice President, Manufacturing28,000——28,000—
Sep 13, 2016 AForm 4 →Sep 15, 6:53 pm EDTSanjay ShuklaChief Medical Officer27,500——27,500—
Sep 13, 2016 AForm 4 →Sep 15, 6:47 pm EDTGrove MatsuokaSee Remarks20,000——20,000—
Sep 13, 2016 AForm 4 →Sep 15, 6:37 pm EDTJohn T BlakeVice President, Finance19,000——19,000—
May 24, 2016 AForm 4 →May 26, 4:37 pm EDTJames C BlairDirector18,000——18,000—
May 24, 2016 AForm 4 →May 26, 11:07 am EDTPaul SchimmelDirector18,000——18,000—
May 24, 2016 AForm 4 →May 26, 11:07 am EDTAmir NashatDirector18,000——18,000—
May 24, 2016 AForm 4 →May 26, 11:06 am EDTMark Alan GoldbergDirector18,000——18,000—
May 24, 2016 AForm 4 →May 26, 11:06 am EDTKathryn E FalbergDirector18,000——18,000—
May 24, 2016 AForm 4 →May 26, 11:05 am EDTJohn K ClarkeDirector18,000——18,000—
May 24, 2016 AForm 4 →May 26, 11:04 am EDTSrinivas AkkarajuDirector18,000——18,000—
May 3, 2016 AForm 4 →May 3, 7:50 pm EDTGrove MatsuokaSee Remarks145,000——145,000—
Mar 30, 2016 AForm 4 →Apr 1, 8:50 pm EDTSanjay ShuklaChief Medical Officer163,000——163,000—
Mar 28, 2016 AForm 4 →Mar 30, 9:01 pm EDTAndrew CubittVP, Product Protection13,000——13,000—
Mar 28, 2016 AForm 4 →Mar 30, 9:00 pm EDTKelly BlackburnVP, Clinical Affairs21,600——21,600—
Jan 27, 2016 AForm 4 →Jan 29, 6:47 pm ESTSrinivas AkkarajuDirector19,428——19,428—
Jan 27, 2016 AForm 4 →Jan 29, 6:21 pm ESTAmir NashatDirector19,428——19,428—
Jan 27, 2016 AForm 4 →Jan 29, 6:10 pm ESTStan BlackburnActing Chief Financial Officer4,250——4,250—
Jan 27, 2016 AForm 4 →Jan 29, 6:08 pm ESTPaul SchimmelDirector19,428——19,428—
Jan 27, 2016 AForm 4 →Jan 29, 6:08 pm ESTNancy KruegerVP, Legal Affairs20,000——20,000—
Jan 27, 2016 AForm 4 →Jan 29, 6:07 pm ESTMark Alan GoldbergDirector19,428——19,428—
Jan 27, 2016 AForm 4 →Jan 29, 6:07 pm ESTMelissa A. AshlockSee Remarks18,250——18,250—
Jan 27, 2016 AForm 4 →Jan 29, 6:06 pm ESTKathryn E FalbergDirector19,428——19,428—
Jan 27, 2016 AForm 4 →Jan 29, 6:06 pm ESTKelly BlackburnVP, Clinical Affairs18,250——18,250—
Jan 27, 2016 AForm 4 →Jan 29, 6:05 pm ESTJohn MendleinCEO and Director, Director135,000——135,000—
Jan 27, 2016 AForm 4 →Jan 29, 6:04 pm ESTJohn C. McKewVP, Research40,000——40,000—
Jan 27, 2016 AForm 4 →Jan 29, 6:04 pm ESTJohn K ClarkeDirector19,428——19,428—
Jan 27, 2016 AForm 4 →Jan 29, 6:03 pm ESTJohn T BlakeVice President, Finance20,000——20,000—
Jan 27, 2016 AForm 4 →Jan 29, 6:02 pm ESTHolly D. ChrzanowskiSee Remarks8,500——8,500—
Jan 27, 2016 AForm 4 →Jan 29, 6:01 pm ESTAndrew CubittVP, Product Protection8,500——8,500—
Jan 27, 2016 AForm 4 →Jan 29, 12:04 pm ESTJames C BlairDirector19,428——19,428—
Jan 4, 2016 AForm 4 →Jan 6, 8:30 pm ESTJohn MendleinCEO and Director, Director148,732——148,732—
Jan 4, 2016 AForm 4 →Jan 6, 8:29 pm ESTJohn C. McKewVP, Research25,913——25,913—
Jan 4, 2016 AForm 4 →Jan 6, 8:29 pm ESTNancy KruegerVP, Legal Affairs10,831——10,831—
Jan 4, 2016 AForm 4 →Jan 6, 8:28 pm ESTMarcy GrahamSee Remarks12,023——12,023—
Jan 4, 2016 AForm 4 →Jan 6, 8:27 pm ESTAndrew CubittVP, Product Protection16,874——16,874—
Jan 4, 2016 AForm 4 →Jan 6, 8:27 pm ESTHolly D. ChrzanowskiSee Remarks14,829——14,829—
Jan 4, 2016 AForm 4 →Jan 6, 8:26 pm ESTJohn T BlakeVice President, Finance5,038——5,038—
Jan 4, 2016 AForm 4 →Jan 6, 8:25 pm ESTStan BlackburnSee Remarks5,754——5,754—
Jan 4, 2016 AForm 4 →Jan 6, 8:23 pm ESTKelly BlackburnVP, Clinical Affairs26,470——26,470—
Jan 4, 2016 AForm 4 →Jan 6, 8:23 pm ESTMelissa A. AshlockSee Remarks29,659——29,659—
Jan 4, 2016 AForm 4 →Jan 6, 8:22 pm ESTSanuj K. RavindranChief Business Officer163,750——10,750—
Oct 28, 2015 AForm 4 →Oct 30, 6:07 pm EDTJohn T BlakeVice President, Finance7,500——7,500—
Oct 1, 2015 AForm 4 →Oct 5, 6:56 pm EDTFred RamsdellVP, Immunology17,393——5,393—
Oct 1, 2015 AForm 4 →Oct 5, 6:56 pm EDTJohn MendleinSee Remarks, Director136,070——65,070—
Oct 1, 2015 AForm 4 →Oct 5, 6:56 pm EDTJohn C. McKewVP, Research34,337——11,337—
Oct 1, 2015 AForm 4 →Oct 5, 6:55 pm EDTNancy KruegerVP, Legal Affairs21,739——4,739—
Oct 1, 2015 AForm 4 →Oct 5, 6:55 pm EDTMarcy GrahamSee Remarks33,260——5,260—
Oct 1, 2015 AForm 4 →Oct 5, 6:53 pm EDTAndrew CubittVP, Product Protection30,382——7,382—
Oct 1, 2015 AForm 4 →Oct 5, 6:53 pm EDTHolly D. ChrzanowskiSee Remarks30,488——6,488—
Oct 1, 2015 AForm 4 →Oct 5, 6:51 pm EDTStan BlackburnSee Remarks12,018——2,518—
Oct 1, 2015 AForm 4 →Oct 5, 6:50 pm EDTKelly BlackburnVP, Clinical Affairs57,081——11,581—
Oct 1, 2015 AForm 4 →Oct 5, 6:49 pm EDTMelissa A. AshlockSee Remarks42,976——12,976—
Jul 8, 2015 AForm 4 →Jul 10, 6:57 pm EDTKathryn E FalbergDirector6,286——6,286—
Jul 8, 2015 AForm 4 →Jul 10, 6:54 pm EDTPaul SchimmelDirector6,286——6,286—
Jul 8, 2015 AForm 4 →Jul 10, 6:53 pm EDTMark Alan GoldbergDirector6,286——6,286—
Jul 8, 2015 AForm 4 →Jul 10, 6:50 pm EDTAmir NashatDirector6,286——6,286—
Jul 8, 2015 AForm 4 →Jul 10, 6:50 pm EDTSrinivas AkkarajuDirector6,286——6,286—
Jul 8, 2015 AForm 4 →Jul 10, 6:47 pm EDTJohn K ClarkeDirector6,286——6,286—
Jul 8, 2015 AForm 4 →Jul 10, 11:16 am EDTJames C BlairDirector, 10% Owner6,286——6,286—